We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Easing Bronchoconstriction in Elite Athletes

By HospiMedica staff writers
Posted on 26 Nov 2003
A study has demonstrated that three weeks of dietary supplementation with fish oil capsules markedly reduces the severity of exercise-induced bronchoconstriction (EIB) in elite athletes. More...
The findings were published in the November 15, 2003, issue of the American Journal of Respiratory and Critical Care Medicine.

EIB is a condition characterized by transient airway narrowing either during or after exercise that results in a reduction of post-exercise pulmonary function. In the study, 10 elite athletes with EIB and 10 elite athletes without EIB entered the study on their normal diet and then received either fish oil capsules containing omega-3 polyunsaturated fatty acids (PUFA) or placebo capsules filled with olive oil daily for three weeks. In subjects with EIB, the PUFA diet improved post-exercise pulmonary function, compared with normal and placebo diets.

When measured at 15 minutes after exercise, pulmonary function test results showed a 3% decrease in PUFA diet participants, compared with a 14.5% decrease on the placebo diet, and a 17.3 percent decrease on the normal diet. Pro-flammatory mediators all decreased significantly on the fish oil diet compared to the other two diets. The study involved 10 triathletes, five cross-country runners, and five track runners. Participants were equally divided between males and females. The study was conducted by Timothy D. Mickleborough, Ph.D., department of kinesiology, Indiana University (Bloomington, USA), and colleagues from the University of Wales (Cardiff).




Related Links:
Indiana Univ.
Univ. of Wales

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.